Affimed Announces Third Quarter 2016 Financial Results and Corporate Update Conference Call October 26, 2016
Affimed Presents Preclinical Data on Lead Candidate AFM13 at the Annual Meeting of the Society for Natural Immunity October 4, 2016
Affimed to Present at the Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology September 22, 2016
Affimed Reports Financial Results for Second Quarter 2016 and Provides Corporate Update August 10, 2016
Affimed Announces Second Quarter 2016 Financial Results and Corporate Update Conference Call August 3, 2016